Nupur Kikani, M.D.
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
In the News
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, HOUSTON, TX
Education & Training
Degree-Granting Education
| 2016 | Baylor College of Medicine, Houston, Texas, US, General Medicine, Doctorate of Medicine (MD) |
| 2011 | Rice University, Houston, Texas, US, Economics, Bachelor of Arts |
Postgraduate Training
| 2019-2021 | Clinical Fellowship, Endocrinology, Diabetes and Metabolism Fellow, Baylor College of Medicine, Houston, Texas |
| 2016-2019 | Clinical Residency, Internal Medicine, Baylor College of Medicine, Houston, Texas |
Licenses & Certifications
| 2024 | American Board of Internal Medicine Endocrinology, Diabetes and Metabolism |
| 2021 | Texas Medical Board License |
| 2019 | American Board of Internal Medicine |
Experience & Service
Administrative Appointments/Responsibilities
Director, Endocrine IOTOX Programs - Clinical, Department of Endocrine Neoplasia & HD, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2025 - Present
Patient Safety and Quality Officer, Department of Endocrine Neoplasia & HD, The University of Texas MD Anderson Cancer Center, 2025 - Present
Associate Patient Safety Quality Officer, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - 2025
Wellness Lead and Department Representative on DoIM Wellness Committee, Department of Endocrine Neoplasia & HD, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
Intramural Institutional Committee Activities
Member, Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, DOIM Education Committee, The University of Texas MD Anderson Cancer Center, 2023 - 2024
Extramural Institutional Committee Activities
Invited Member, IOTOX Clinical Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Executive Board Member, Academy of Resident Educators, Baylor College of Medicine, The University of Texas MD Anderson Cancer Center, 2017 - 2019
Department representative, Internal Medicine Faculty Wellness Committee, The University of Texas MD Anderson Cancer Center
Honors & Awards
| 2019 | Academy of Resident Educators Distinguished Educator |
| 2015 | Effie and Wofford Cain Scholar |
| 2007 - 2016 | Rice - Baylor Medical Scholar |
| 2007 - 2011 | National Merit Scholar |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Systemic Toxicity with Hyperglycemia and Diabetic Ketoacidosis after Enfortumab Vedotin therapy. Invited. Endocrine Research Seminar Series. Houston, Texas, US.
- 2025. Immunotherapy Related Adverse Events in Endocrinology. Invited. Institutional IOTOX Educational Lecture Series. Houston, Texas, US.
- 2025. Immunotherapy-related adverse events in Endocrinology – initial recognition and management. Invited. General Internal Medicine Clinical and Research Conference. Houston, Texas, US.
- 2025. Immunotherapy Induced Diabetes Mellitus in the Oncology Population. Invited. Glycemic Management Committe Diabetes Lecture Series. Houston, Texas, US.
- 2025. Improving Access and Outcomes for Immune-Related Thyroid Dysfunction. Invited. Institutional IOTOX Research Seminar Series. Houston, Texas, US.
- 2024. Non-insulin therapy Overview in the Oncology Population. Invited. Glycemic Management Committee Diabetes Lecture Series. Houston, Texas, US.
- 2023. Insulin Pumps and Continuous Glucose Monitoring in the Oncology Patient. Invited. Glycemic Management Committee Diabetes Lecture Series. Houston, Texas, US.
- 2019. Improving Patient Safety Through Information: Implementation of an Overnight Handoff System. Conference. Improving Patient Safety Through Information: Implementation of an Overnight Handoff System. Houston, TX, US.
- Fadraciclib: A case report on severe hyperglycemia after initiation of this cancer therapy in relation with CDK2 activity. Poster. ancer Nursing Conference: Transforming Cancer Nursing Care through Quality Improvement, Evidence-Based Practice, and Research. Houston, Texas, US.
Regional Presentations
- 2025. Update in Insulin Pumps and Continuous Glucose Monitors. Invited. Texas AACE, US.
National Presentations
- 2024. Endocrine Immune related adverse events. Invited. 2024 IOTOX Symposium: Treating Immune-Related Adverse Events – Integrating Insights from Clinical, Translational and Basic Science. Houston, Texas, US.
- 2023. Immunotherapy related adverse events in Endocrinology. Invited. 2023 IOTOX Symposium: Treating Immune-Related Adverse Events – Integrating Insights from Clinical, Translational and Basic Science. Houston, Texas, US.
- 2020. A Lipomatous problem: a case of familial hypercholesterolemia. Conference. AACE Innovation in Cardiometabolic Clinical Practice. Virtual, US.
International Presentations
- 2023. Identifying Trends in Glycemic Management in a Comprehensive Cancer Center. Conference. Endocrine Society Meeting 2023. Chicago, US.
- 2021. Serum Branch Chain Amino Acids (BCAAs) Are Elevated Due to Decreased Catabolism in Patients with Ketosis-Prone Diabetes at the Time of Presentation With DKA. Conference. Endocrine Society Meeting 2021. Virtual, US.
- 2018. Cry, Cry Again: A Case of Idiopathic Cryoglobulinemia. Conference. American Society of Nephrology Kidney Week. San Diego, US.
- 2018. Addition of Everolimus to Lenvatinib Halts Tumor Progression in Differentiated Thyroid Cancer. Conference. 88th Annual Meeting of the American Thyroid Association. Washington, US.
Selected Publications
Peer-Reviewed Articles
- Kikani N, Wilson N, Ghosh A, Bhattacharjee M, Curry J, Cho W, Patel A, Habra A, Thoani S, Campbell M, Siefker-Radtke A, Alhalabi O. Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin: Single-Center Case Series. Annals of Internal Medicin: Clinical Cases 4(5).
Review Articles
- Kotwal, A, Kennedy, R, Kikani, NJ, Thosani, S, Goldner, WS, Shariff, A. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use. Endocrine Practice 30(6):584-591, 2024. e-Pub 2024. PMID: 38554775.
- Kikani, NJ, Balasubramanyam, A. Remission in Ketosis-Prone Diabetes. Endocrinology and Metabolism Clinics of North America 52(1):165-174, 2023. e-Pub 2023. PMID: 36754492.
- Iyer P, Thosani S, Varghese J, Best C, Lavis V, Mehta P, Khan S, Chaudhri A, Dadu R, Pagnotti G, Aguirre R, Weitzman S, Guise T, Gandhi A. Beyond the known and the unknown of immunotherapy mediated endocrinopathies and their management.
Abstracts
- Monroy A, Khan S, Kikani N, Brady VJ, Thosani SN. Fadraciclib induced hyperglycemia. American Association of Clinical Endocrinology (AACE), 2024. e-Pub 2024.
- Thosani S, Grami P, Crowder V, Kikani N. Sweet success: Implementation of institution wide glycemic management initiative. International Forum on Quality and Safety in Healthcare, 2024. e-Pub 2024.
- Kikani N, Thosani S. Use of Continuous Glucose Monitoring System versus Capillary Point of care testing for inpatient Glucose monitoring in a cancer hospital. ENDO 2023 (Endocrine Society), 2023. e-Pub 2023.
- Kikani N, Thosani S. Identifying Trends in Glycemic Management in the Acute Cancer Care Center at MD Anderson Cancer Center. Oncologic Emergency Medicine Conference. e-Pub 2023.
- Weitzman S, Kikani N, Brinkman A, Salami-Henry A. Immune Checkpoint Inhibitor Related Thyroid Dysfunction: A Quality Improvement Project to Improve Access to Endocrine Care and Expedite Normalization of Thyroid Hormone Levels. ENDO 2024.
- Williams J, Kikani N, Weitzman S. A Unique Patient With Immune Checkpoint Inhibitor-Induced Thyroiditis: What’s the Kidney Have to Do With It?.
- Thosani S, Grami P, Crowder V, Kikani N. Sweet success: Implementation of institution wide glycemic management initiative. Patient Safety Awareness Week.
- Rizk M, Kikani N. Recurrence of Multiple Myeloma Presenting as a Thyroid Plasmacytoma in a Patient with Long-standing Thyroid Nodules. ENDO 2025.
- Kikani N, Montes G, Gaba R, Liao G, Tosur M, Redondo M, Balasubramanyam A. Identifying Atypical Diabetes Using i2b2 Algorithms in Electronic Health Records. American Diabetes Association 82nd Scientific Sessions.
Book Chapters
- Kikani N, Balasubramanyam A. Impact of HIV on the Hypothalamic-Pituitary Hormonal Axis. In: Pituitary Disorders throughout the Life Cycle. Springer Nature, 2022.
- Kikani N, Gaba R. Primer on Graves’ disease – what the ophthalmologist should know and do. In: International Ophthalmology Clinics: Winter, 2021.
Web Publications
- Kikani N, Weitzman S. 10 thyroid myths you shouldn’t believe.
Patient Reviews
CV information above last modified March 30, 2026